Quality of life and clinical trials

The Lancet

Volumn 346, Issue 8966, 1995, Pages 1-2

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EDITORIAL; HUMAN; QUALITY OF LIFE; TREATMENT OUTCOME; CANCER THERAPY; COST EFFECTIVENESS ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; SELF EVALUATION; SURVIVAL;

CLINICAL TRIALS; HUMAN; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0028989207     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92643-7     Document Type: Editorial

References (16)

1. Quality of life
2. A critical appraisal of the quality of quality-of-life measurements
3. The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions
4. Food and Drug Administration requirements for approval of new anti-cancer drugs
5. Registration of drugs for treating cancer and HIV infection: a plea to carry out phase 3 trials before admission to the market
6. Public health and chronic diseases
7. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma
8. The rights of patients in research
9. Who should measure quality of life, the doctor or the patient?
10. Quality of life: philosophical question or clinical reality?
11. Breast cancer: clearing trails in the forest without losing our way
12. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy
13. The effects of antihypertensive therapy on the quality of life
14. Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC: results of a randomized prospective study
15. Quality-of-life assessment in cancer treatment protocols: research issues in protocol development